Atom Investors’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,721
Closed -$901K 714
2024
Q1
$901K Buy
+22,721
New +$670K 0.11% 236

Atom Investors's ALPN Position: Q2 2024 in Review

Atom Investors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 22,721 shares — an estimated $901K sold.

Atom Investors first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $901K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Atom Investors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Atom Investors sold 22,721 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $901K.
  • Atom Investors first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
  • Atom Investors's Alpine Immune Sciences Inc position peaked at $901K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Atom Investors's 13F filing for Q2 2024, filed 14 Aug 2024.